Overview

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

Status:
Completed
Trial end date:
2019-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate BMS-986165 in participants with different levels of liver function.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165